Neurocrine Biosciences (NBIX) Gross Profit (2017 - 2026)
Neurocrine Biosciences (NBIX) posted quarterly Gross Profit of $935.8 million for Q2 2026, up 38.19% year-over-year from $677.2 million in Q2 2025, and up 16.87% on a QoQ basis from $800.7 million in Q1 2026.
Neurocrine Biosciences (NBIX) Gross Profit (2017 - 2026) Analysis & Trends
Neurocrine Biosciences has reported Gross Profit for 10 years, with the latest figure at $935.8 million in Q2 2026.
- Gross Profit for Q2 2026 came in at $935.8 million, up 38.19% year-over-year; the trailing twelve-month figure through Jun 2026 was $3.3 billion (up 33.65% YoY), and the FY2025 annual result was $2.8 billion, up 20.98% from the prior year.
- Gross Profit climbed to $935.8 million in Q2 2026, from $800.7 million in the prior quarter.
- Over five years, Gross Profit peaked at $935.8 million in Q2 2026 and troughed at $15.2 million in Q2 2022.
- A 5-year average of $545.7 million and a median of $535.6 million in 2024 frame the typical range for Gross Profit.
- The widest annual swing landed in 2022, when Gross Profit tumbled 94.68%; it then surged 2802.63% in 2023.
- A 5-year view of Gross Profit shows it stood at $404.3 million in 2022, then gained by 25.33% to $506.7 million in 2023, then advanced by 22.04% to $618.4 million in 2024, then advanced by 27.41% to $787.9 million in 2025, then grew by 18.77% to $935.8 million in 2026.
- Per Business Quant data, the three most recent Gross Profit figures were $935.8 million in Q2 2026, $800.7 million in Q1 2026, and $787.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.19 Bn | 7.53 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 935.80 Mn |
| Jun 30, 2026 | 935.80 Mn |
| Mar 31, 2026 | 800.70 Mn |
| Mar 31, 2026 | 800.70 Mn |
| Dec 31, 2025 | 787.90 Mn |
| Dec 31, 2025 | 787.90 Mn |
| Sep 30, 2025 | 780.90 Mn |
| Sep 30, 2025 | 780.90 Mn |
| Jun 30, 2025 | 676.20 Mn |
| Jun 30, 2025 | 676.20 Mn |
| Mar 31, 2025 | 563.40 Mn |
| Mar 31, 2025 | 563.40 Mn |
| Dec 31, 2024 | 618.40 Mn |
| Dec 31, 2024 | 618.40 Mn |
| Sep 30, 2024 | 614.10 Mn |
| Sep 30, 2024 | 614.10 Mn |
| Jun 30, 2024 | 581.00 Mn |
| Jun 30, 2024 | 581.00 Mn |
| Mar 31, 2024 | 507.80 Mn |
| Mar 31, 2024 | 507.80 Mn |